ARTICLE | Company News
Hikma Pharmaceuticals, Theravance sales and marketing update
July 15, 2013 7:00 AM UTC
Hikma received exclusive rights to develop and commercialize Theravance's Vibativ telavancin in 16 countries in the Middle East and North Africa region. Hikma will be responsible for obtaining regula...